THE 2-MINUTE RULE FOR ABBV-744 IN THE TREATMENT OF DRUG-RESISTANT CANCERS

These side effects have been notably milder in comparison to an inhibitor of both of those bromodomains. A detailed molecular Examination also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen TaylorFeasible new approaches for the prognosis and treatment of AML. (A) The identifica